Lv11
50 积分 2024-03-11 加入
Utidelone plus pembrolizumab as the fourth-line combination treatment in non-small cell lung cancer with EGFR mutation: a case report
2小时前
待确认
Spatiotemporal Quantification of HER2-targeting Antibody-Drug Conjugate Bystander Activity and Enhancement of Solid Tumor penetration
1个月前
已完结
Bystander effect of antibody–drug conjugates: fact or fiction?
1个月前
已完结
Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Early Breast Cancer A Systematic Review and Meta-Analysis
3个月前
已关闭
Alpha-fetoprotein-producing gastric cancer with ruptured liver metastasis mimicking hepatocellular carcinoma
4个月前
已完结
Endometriosis Typology and Ovarian Cancer Risk
4个月前
已关闭
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
9个月前
已完结
皖公网安备34019202002308
